Table 3 Number of events, incidence rates, adjusted HRs, and 95% CI
| Â | Number of events | Incidence rate | 95% CI | Hazard ratio | 95% CI |
|---|---|---|---|---|---|
All cause mortality | Â | Â | Â | Â | Â |
  Follow-up start at index PCI |  |  |  |  |  |
  Mild psoriasis | 107 | 29.9 | 24.7-36.1 | 1.10 | 0.91-1.33 |
  Severe psoriasis | 43 | 47.2 | 35.0-63.6 | 1.67 | 1.24-2.26 |
  Follow-up start at day 30 |  |  |  |  |  |
  Mild psoriasis | 85 | 24.3 | 19.7-30.1 | 1.13 | 0.91-1.40 |
  Severe psoriasis | 38 | 42.8 | 31.1-58.8 | 1.78 | 1.30-2.46 |
Composite endpoint | Â | Â | Â | Â | Â |
  Follow-up start at index PCI |  |  |  |  |  |
  Mild psoriasis | 128 | 37.3 | 31.4-44.4 | 1.07 | 0.90-1.28 |
  Severe psoriasis | 48 | 55.4 | 41.8-73.5 | 1.54 | 1.16-2.05 |
  Follow-up start at day 30 |  |  |  |  |  |
  Mild psoriasis | 90 | 26.9 | 21.9-33.1 | 1.10 | 0.90-1.36 |
  Severe psoriasis | 38 | 45.1 | 45.1 32.8-61.1 | 1.66 | 1.21-2.28 |